Novo led a $60m series B round for achondroplasia drug developer Therachon that also featured Pfizer Ventures.

The oversubscribed round included Pfizer, Novartis, Merck Group and AbbVie, and boosted the cancer drug developer's overall funding to $120m.

Therachon has welcomed back Inserm Transfert Initiative for its series B round, led by Novo.

Existing shareholder IP Group has returned to back an $84m series B round for Artios, which also attracted corporates Pfizer, Novartis, AbbVie and Merck Group.

ICL spinout Cagen raised an undisclosed sum from Imperial Innovations and UKI2S to commercialise protein nanocages for shielding therapeutic payloads.

ING is supplying $24.5m in funding for cross-border payment platform TransferMate, nine months after a $35m investment by fellow bank AIB.

SEB subsidiary SEB Venture Capital contributed to a $12.7m round for the software performance-monitoring technology developer, which has raised $35m in total.

Frontier IP will take a 31.8% shareholding in NTPE, an electronics printing technology spinout from Universidade Nova de Lisboa.